翻訳と辞書 |
Daniel Von Hoff : ウィキペディア英語版 | Daniel Von Hoff
Daniel D. Von Hoff, M.D., F.A.C.P. is a medical oncologist and oncology drug developer who has conducted national clinical trials with more than 200 new antineoplastic and biologic agents. Dr. Von Hoff's major interest is in the development of new anticancer agents, both in the clinic and in the laboratory. Dr. Von Hoff and his colleagues have conducted early clinical investigations of most of the new agents that have been approved for cancer treatment in the United States in the last two decades, including gemcitabine, docetaxel, paclitaxel, topotecan, irinotecan, fludarabine, mitoxantrone, dexrazoxane, nab-paclitaxel, and multiple others. At present, he and his colleagues are concentrating on the development of molecularly targeted therapies for individual patients with cancer. For more than 30 years, Dr. Von Hoff has dedicated his time and experience to the study of cancer and treatment methods. Among his significant activities: • 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Daniel Von Hoff」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|